DAYVIGO (LEMBOREXANT) — FDA Approval NDA212028 (EISAI INC)
DAYVIGO (LEMBOREXANT) — FDA Approval NDA212028 (EISAI INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DAYVIGO; Active ingredients: LEMBOREXANT; Application number: NDA212028.
| Brand name | DAYVIGO |
|---|---|
| Active ingredients | LEMBOREXANT |
| Application number | NDA212028 |
| Sponsor | EISAI INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20191220 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →